ERBB2 and neoplasm: Moreover, for BRCA1 mutation carriers, nFTH1 expression in the tumor was associated with smaller tumor size (p = 0.045) and positive HER2 status (p = 0.049), while in BRCA2 mutation carriers, nFTH1 expression was associated with positive ER status (p = 0.004; Table 3).